Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,758,740 papers from all fields of science
Search
Sign In
Create Free Account
FK749
Known as:
FK 749
, FK-749
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Ceftizoxime
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1984
1984
Ceftizoxime (FK‐749) Is Effective Therapy for Urethritis Caused by Penicillinase‐producing Neisseria gonorrhoeae
W. O. Harrison
,
P. Sanchez
,
D. Lancaster
,
S. Kerbs
,
S. W. Berg
Sexually transmitted diseases
1984
Corpus ID: 38013989
Fifty-five men with culture-proved gonococcal urethritis caused by either penicillin-sensitive or penicillinase-producing…
Expand
1983
1983
Pharmacokinetics of ceftizoxime in subjects with various degrees of renal function
S. Kowalsky
,
R. Echols
,
A. Venezia
,
E. Andrews
Antimicrobial Agents and Chemotherapy
1983
Corpus ID: 36036951
The pharmacokinetics of ceftizoxime (FK-749) were studied in 20 volunteers with various degrees of renal function. Creatinine…
Expand
Highly Cited
1981
Highly Cited
1981
In vitro antimicrobial activity evaluation of cefodizime (HR221), a new semisynthetic cephalosporin
R. Jones
,
A. Barry
,
C. Thornsberry
,
H. W. Wilson
Antimicrobial Agents and Chemotherapy
1981
Corpus ID: 43654313
Cefodizime (HR221) is a new alpha-methoxyimino cephalosporin developed by Hoechst-Roussel with a reported serum half-life of over…
Expand
1981
1981
Properties of cephalosporinase from Proteus morganii.
M. Toda
,
M. Inoue
,
S. Mitsuhashi
The Journal of antibiotics
1981
Corpus ID: 35022402
The cephalosporin beta-lactamase (cephalosporinase) was purified from a strain of Proteus morganii which showed resistance to…
Expand
1980
1980
Comparative in vitro activities of cefotaxime and ceftizoxime (FK749): new cephalosporins with exceptional potency
D. Greenwood
,
N. Pearson
,
A. Eley
,
F. O'grady
Antimicrobial Agents and Chemotherapy
1980
Corpus ID: 29995366
Cefotaxime and its desacetoxymethyl derivative, ceftizoxime (previously known as FK749), are both extremely active against a wide…
Expand
1980
1980
Synthesis and antibacterial activity of new 1-oxa-1-dethiacephalosporins.
D. Hagiwara
,
H. Takeno
,
M. Aratani
,
K. Hemmi
,
M. Hashimoto
Journal of medicinal chemistry
1980
Corpus ID: 41639170
A series of 3-(deacetoxymethyl)-1-oxa-1-dethiacephalosporins (1) bearing the 7-(alpha-alkoxyimono)acyl side chain were…
Expand
1980
1980
Purification and biochemical properties of beta-lactamase produced by Proteus rettgeri
M. Matsuura
,
H. Nakazawa
,
M. Inoue
,
S. Mitsuhashi
Antimicrobial Agents and Chemotherapy
1980
Corpus ID: 33854201
beta-Lactamase produced by Proteus rettgeri was found to be a typical cephalosporin beta-lactamase on the basis of its substrate…
Expand
Highly Cited
1979
Highly Cited
1979
Ceftizoxime (FK 749), a new parenteral cephalosporin: in vitro and in vivo antibacterial activities
T. Kamimura
,
Y. Matsumoto
,
+4 authors
S. Kuwahara
Antimicrobial Agents and Chemotherapy
1979
Corpus ID: 28762278
FK 749 is a new parenteral cephalosporin derivative which is more active against various gram-negative bacilli, including the…
Expand
1979
1979
Comparison of antibacterial activity of a new cephalosporin, ceftizoxime (FK 749) with other cephalosporin antibiotics.
M. Nishida
,
T. Kamimura
,
+5 authors
S. Kuwahara
The Journal of antibiotics
1979
Corpus ID: 10471628
FK 749 is a distinctive new parenteral cephalosporin antibiotic with a broad antibacterial spectrum which is more potently active…
Expand
1979
1979
Antibacterial activity of ceftizoxime (FK 749), a new cephalosporin, against cephalosporin-resistant bacteria, and its stability to beta-lactamase
H. Kojo
,
M. Nishida
,
S. Goto
,
S. Kuwahara
Antimicrobial Agents and Chemotherapy
1979
Corpus ID: 24937574
Antibacterial activity of FK 749 against ampicillin-resistant clinical isolates of Escherichia coli was compared with those of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE